Document Detail


Effects of pollen extract in association with vitamins (DEPROX 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study.
MedLine Citation:
PMID:  23334883     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: The therapeutic efficacy of CP/CPPS is not very satisfactory and the impact on young male's quality of life is considerable. The aim of the present study is to evaluate the efficacy of pollen extract associated with vitamins (DEPROX 500®) in order to improve the quality of life of young patients affected by chronic prostatitis type IIIb (CP/CPPS) by pain relieving.
Methods: All patients with clinical and instrumental diagnosis of CP/CPPS (class b) underwent DEPROX 500® 2 tablets in a single dose daily for 30 days. Clinical and microbiological analyses were carried out at the enrolment and after 1 month. NIH-CPSI and IPSS questionnaires have been used. The main outcome measure was the improvement of quality of life at the end of the whole study period, evaluated by questionnaires results.
Results: 20 men (mean age 32.8 ± 6.78) were enrolled in this pilot study. The baseline questionnaire mean scores were 25.90 ± 2.1 and 8.01 ± 3.64 for NIH-CPSI and IPSS, respectively. At the follow-up examination (1 month after treatment), 18 out of 20 patients (90.0%) reported an improvement of quality of life, in terms of pain reduction. The questionnaire results after 1 month from treatment were as follows: NIH-CPSI 12.8 ± 2.20, IPSS 7.6 ± 1.58. Statistically significant differences were then reported between the two visits, in terms of NIH-CPSI scores (p<0.001). No statistically significant differences have been reported in terms of IPSS between the two groups. All patients were negative at the Meares-Stamey test evaluation. The compliance to the study protocol 
was 100%.
Conclusions: The pollen extract associated with vitamins (DEPROX 500®) significantly improved 
total symptoms, pain, and QoL in patients with non-inflammatory CP/CPPS without severe side 
effects.
Authors:
Tommaso Cai; Lorenzo Giuseppe Luciani; Iole Caola; Nicola Mondaini; Gianni Malossini; Paolo Lanzafame; Sandra Mazzoli; Riccardo Bartoletti
Related Documents :
22490483 - Effect of basic fibroblast growth factor and transforming growth factor β1 on the heal...
24385033 - External rotation immobilization for primary shoulder dislocation: a randomized control...
23956943 - Comparison of total versus partial revision of primary ventriculoperitoneal shunt failu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-16
Journal Detail:
Title:  Urologia     Volume:  0     ISSN:  0391-5603     ISO Abbreviation:  Urologia     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417372     Medline TA:  Urologia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  0     Citation Subset:  -    
Affiliation:
Department of Urology, Santa Chiara Regional Hospital, Trento - Italy.
Vernacular Title:
Effects of pollen extract in association with vitamins (deprox 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study 
<Tabella xmlns:aid="http://ns.adobe.com/AdobeInDesign/4.0/" aid:table="table" aid:trows="7" aid:tcols="5"><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_42_TABLE_FIRST_LINE>Tipo Terapia Ormonale</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_42_TABLE_FIRST_LINE>Numero 
pazienti</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_42_TABLE_FIRST_LINE>pazienti liberi 
da malattia (%)</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_42_TABLE_FIRST_LINE>Pazienti con recidiva biochimica (%)</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_42_TABLE_FIRST_LINE>Pazienti con recidiva locale/linfonodale (%)</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>neoadiuvante - concomitante - adiuvante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>181</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>151 (83.4%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>27 (14.9%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>3 (1.7%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>neoadiuvante - concomitante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>15</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>10 (66.7%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>5 (33.3%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>concomitante - adiuvante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>15</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>10 (66.7%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>5 (33.3%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>neoadiuvante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>2</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>2 (100%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>concomitante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>2</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>2 (100%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="124.00196850393706"><_44_TABLE_MAIN_BODY>adiuvante</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="72"><_44_TABLE_MAIN_BODY>1</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>1 (100%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="104.57808398944091"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="105.07808398944097"><_44_TABLE_MAIN_BODY>/</_44_TABLE_MAIN_BODY></Cella></Tabella><Tabella xmlns:aid="http://ns.adobe.com/AdobeInDesign/4.0/" aid:table="table" aid:trows="11" aid:tcols="3"><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="52.923228346276005"></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="82.20472440944877"><_42_TABLE_FIRST_LINE>1-3 mesi</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_42_TABLE_FIRST_LINE>Follow-up a lungo termine</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY>Stone free</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="82.20472440944877"><_44_TABLE_MAIN_BODY>83 pz (72.1%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Stone free: 54 (65%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Recidive: 29 (35%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY>< 4 mm</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="82.20472440944877"><_44_TABLE_MAIN_BODY>23 pz (20%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Ricrescite: 10 (46%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Stone free: 13 (54%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY> 4 mm</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="82.20472440944877"><_44_TABLE_MAIN_BODY>4 pz (3.5%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Ricrescite: 3 (72%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Invariati: 1 (28%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY>Invariati</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="2" aid:ccols="1" aid:ccolwidth="82.20472440944877"><_44_TABLE_MAIN_BODY>5 pz (4.3%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Invariati: 2 (40%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>Altra metodica: 3 (60%)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY>Recidiva</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="82.20472440944877"></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>25.9% (29/112)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="52.923228346276005"><_44_TABLE_MAIN_BODY>Ricrescita</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="82.20472440944877"></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834646"><_44_TABLE_MAIN_BODY>11.6% (13/112)</_44_TABLE_MAIN_BODY></Cella></Tabella><Tabella xmlns:aid="http://ns.adobe.com/AdobeInDesign/4.0/" aid:table="table" aid:trows="7" aid:tcols="3"><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_42_TABLE_FIRST_LINE>Tipo di Complicanza</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_42_TABLE_FIRST_LINE>% </_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_42_TABLE_FIRST_LINE>N° pazienti </_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Aritmia/Extrasistolia</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>7.8</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>9</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Iperpiressia (TA>38°C)</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>4.4</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>5</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Nausea e/o Vomito</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>3.5</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>4</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Ipertensione arteriosa</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>3.5</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>4</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Impilamento</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>2.6</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>3</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="111.36417322834654"><_44_TABLE_MAIN_BODY>Ematoma renale</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.29921259824403"><_44_TABLE_MAIN_BODY>0.8</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="67.23818897619682"><_44_TABLE_MAIN_BODY>1</_44_TABLE_MAIN_BODY></Cella></Tabella><Tabella xmlns:aid="http://ns.adobe.com/AdobeInDesign/4.0/" aid:table="table" aid:trows="9" aid:tcols="3"><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="48.05708661417319"></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_42_TABLE_FIRST_LINE>GRUPPO 1
(> 70 anni)</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_42_TABLE_FIRST_LINE>GRUPPO 2 
( < 60 anni)</_42_TABLE_FIRST_LINE></Cella><Cella aid:table="cell" aid:crows="4" aid:ccols="1" aid:ccolwidth="48.05708661417319"><_44_TABLE_MAIN_BODY>Calcolosi 
CALICIALE</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>SF = 30/48 = 62.5%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>SF = 45/64 = 70.3%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>< 4 mm = 15/48 = 31.2%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>< 4 mm = 13/64 = 20.3%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY> 4 mm = 1/48 = 2.1%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY> 4 mm = 4/64 = 6.3%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>invariata = 2/48 = 4.2%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>invariata = 2/64 = 3.1%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="4" aid:ccols="1" aid:ccolwidth="48.05708661417319"><_44_TABLE_MAIN_BODY>Calcolosi NON 
CALICIALE</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>SF = 53/67 = 79.1%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>SF = 41/51 = 80.4%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>< 4 mm = 9/67 = 13.4%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>< 4 mm = 6/51 = 11.8%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY> 4 mm = 2/67 = 3.0%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY> 4 mm = 3/51 = 5.9%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99"><_44_TABLE_MAIN_BODY>invariata = 3/67 = 4.5%</_44_TABLE_MAIN_BODY></Cella><Cella aid:table="cell" aid:crows="1" aid:ccols="1" aid:ccolwidth="99.0570866141733"><_44_TABLE_MAIN_BODY>invariata = 1/51 = 1.9%</_44_TABLE_MAIN_BODY></Cella></Tabella>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aliifodinibius roseus gen. nov., sp. nov., and Aliifodinibius sediminis sp. nov., two moderately hal...
Next Document:  Use of Frozen Sections to assess surgical margins during radical prostatectomy.